@curator

3 years ago

Article

FDA grants orphan drug designation to CAR T-cell therapy for advanced gastric cancers

Rating: 0.0

Likes: 1

Library: 1

FDA grants orphan drug designation to CAR T-cell therapy for advanced gastric cancers

The FDA granted orphan drug designation to CT041 for the treatment of adults with relapsed or refractory gastric adenocarcinoma or gastroesophageal junction adenocarcinoma, according to the agent’s manufacturer.CT041 (CARsgen Therapeutics) is an autologous chimeric antigen receptor T-cell therapy that targets claudin 18.2, a stomach-specific isoform of claudin 18 that is highly expressed in

Rate This Post

Rate The Educational Value

Rate The Ease of Understanding and Presentation

Interesting or Boring? Rate the Entertainment Value

FDA grants orphan drug designation to CAR T-cell therapy for advanced gastric cancers

Rate This Post

Related Topics

Comments

Media:

My Account:

Boostlane:

Select a Category

Topics Trending Today

Recommended Media

Boostlane Reward System

Unlocking the Power of Knowledge
for Humanity's Progress

Quick Links

Select a Locale

Unlocking the Power of Knowledge
for Humanity's Progress

FDA grants orphan drug designation to CAR T-cell therapy for advanced gastric cancers

Rate This Post

Related Topics

Comments

Media:

My Account:

Boostlane:

Select a Category

Topics Trending Today

Recommended Media

Boostlane Reward System

Unlocking the Power of Knowledge for Humanity's Progress

Quick Links

Select a Locale

Unlocking the Power of Knowledge for Humanity's Progress

Unlocking the Power of Knowledge
for Humanity's Progress

Unlocking the Power of Knowledge
for Humanity's Progress